Key Takeaways and Future in Advanced Gastric Cancer Treatment
Panelists discuss how future analyses in advanced gastric cancer should assess long-term survival, real-world outcomes, biomarkers for response, resistance mechanisms, and patient selection for nivolumab plus chemotherapy. Evaluating these factors will optimize treatment strategies and confirm its role across diverse populations.
- What are some key takeaways from this discussion?
- What will be important to evaluate in future analyses in advanced gastric cancers?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
